MSH2 is Inactivated by Multiple Mechanisms in Prostate Tumors, Leading to a Distinct Immune Response and Clinical Outcome Compared to MSH2 Deficient Colorectal Cancer
Preprint in SSRN Electronic Journal (January 2018)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Retrotransposon Contribution to Genomic Plasticity
Book chapter (January 2017)